Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Clinical trial NCT04797715 · COMPLETED

Trial details

NCT number: NCT04797715
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Agitation in Patients With Dementia of the Alzheimer's Type Alzheimer Disease Agitation,Psychomotor

Start date: 2020-12-31
Primary completion: 2022-11-21
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.